Mercaptopurine and hepatic function abnormal Patient Reports February 12, 2012
Mercaptopurine Side Effects Report #5955730-7
Mercaptopurine side effect was reported by a Consumer or non-health professional from on Nov 13, 2008. Female patient, 43 years of age, was diagnosed with crohn's disease
, prophylaxis, hepatitis b
and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: crohn's disease
, hepatic function abnormal, hepatitis b
. Mercaptopurine dosage: 10MG. During the same period patient was treated with INFLIXIMAB, LAMIVUDINE, CORTICOSTEROIDS, SULFASALAZINE. Patient was hospitalized. Patient recovered.Mercaptopurine Side Effects Report #5753699-1
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 27, 2008. Female patient, weighting 74.08 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: blood lactic acid increased, cerebral haemorrhage, coagulopathy, fungal infection
, hepatic function abnormal, metabolic acidosis, multi-organ failure, neutropenia, pyrexia. Mercaptopurine dosage: 1275 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Mercaptopurine Side Effects Report #5758158-8
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on June 02, 2008. Female patient, weighting 74.08 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: blood lactic acid increased, candiduria, coagulopathy, haemorrhage, hepatic function abnormal, metabolic acidosis, multi-organ failure, nervous system disorder, neutropenia. Mercaptopurine dosage: 1275 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Mercaptopurine Side Effects Report #6050563-8
Mercaptopurine side effect was reported by a Consumer or non-health professional from NEW ZEALAND on Jan 22, 2009. Female patient, weighting 108.0 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, bilirubin conjugated increased, blood bilirubin increased, culture positive, fluid overload, gallbladder disorder, hepatic function abnormal, hepatic vein occlusion. Mercaptopurine dosage: 3600 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, PENTAMIDINE. Patient was hospitalized. Patient recovered.
Mercaptopurine and hepatic function abnormal 